By introducing access to generic semaglutide in Canada, the company is meeting the needs of a dynamic market and continuing its international expansion efforts Nearly two-thirds of Canadian adults are overweight or living with obesity, but cost has remained a significant barrier to access the treatment they need
Wegovy patients in the United States have also experienced NAION, which can cause patients to lose vision in one eye without warning
Some reasons for this high price are: Research and Development: Pharmaceutical companies invest billions of dollars in researching, developing, and testing new drugs
High-protein meals for GLP-1 users should also include fluids, gentle fiber, and tolerable carbohydrates because constipation, dehydration, nausea, and low energy can worsen when protein is planned alone
For a supplier, the relevant argument is functional: an ingredient that allows one to achieve 30g of protein in a reduced format, without organoleptic compromise, meets a real formulation constraint, whether its linked to GLP-1 or not